🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs
5,427

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Page 33 of 114

  1. Etripamil NS 70 mg

    Milestone Pharmaceuticals

    Tachycardia, Supraventricular

    phase 3 small molecule completed

    1 trial

  2. Everolimus

    Jazz Pharmaceuticals Ireland Limited

    Diffuse Intrinsic Pontine Glioma

    phase 3 small molecule active

    1 trial

  3. Everolimus

    United Therapeutics Europe Ltd

    Pediatric Heart Transplantation

    phase 3 small molecule active

    1 trial

  4. Everolimus

    Novartis Pharmaceuticals

    Advanced NET of GI Origin

    phase 3 small molecule completed

    1 trial

  5. Everolimus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Prostate Cancer

    phase 3 small molecule active

    1 trial

  6. Everolimus-ratiopharm® 2,5 mg Tabletten, GOSERELIN , ORSERDU 86 mg film-coated tablets, ORSERDU 345 mg film-coated tablets, LEUPRORELIN , DEXAMETHASONE , The investigational product is as follows: white tablets, elongated, flat, rounded edges, about 10 mm long and 4 mm wide, with the embossing "EV" on one side and "2.5" on the other side. The list of excipients of Placebo tablet is as follows: Lactose monohydrate, Polyplasdone, Cellulose microcrystalline, Magnesium stearate, Hypromellose., TRIPTORELIN

    Stemline Therapeutics B.V.

    patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative, ESR1-mutated, advanced breast cancer progressing to endocrine therapy and CDK4/6 inhibitors.

    phase 3 small molecule active

    1 trial

  7. Evinacumab

    Ultragenyx UK Limited

    Homozygous Familial Hypercholesterolemia

    phase 3 small molecule completed

    1 trial

  8. Evolocumab

    COLLEGIUM PHARMACEUTICAL, INC

    Sars-CoV-2 Infection

    phase 3 small molecule completed

    1 trial

  9. Evolocumab

    Amgen

    Coronary Heart Disease (CHD)

    phase 3 small molecule completed

    1 trial

  10. Evolocumab

    Amgen

    Severe Familial Hypercholesterolemia

    phase 3 mab completed

    1 trial

  11. Evolocumab

    Amgen

    Hyperlipidemia

    phase 3 mab completed

    2 trials

  12. Evolocumab

    Amgen

    Dyslipidemia

    phase 3 mab completed

    1 trial

  13. Evorpacept (ALX148)

    ALX ONCOLOGY HOLDINGS INC

    Gastric Cancer

    phase 3 small molecule active

    1 trial

  14. Exa-cel

    Vertex Pharmaceuticals (Australia) Pty.

    Sickle Cell Disease

    phase 3 mab terminated

    1 trial

  15. Excipients without active substance - Lyophilised powder for solution for injection - Intramuscolar Use

    Ipsen

    Treatment of moderate to severe glabellar lines

    phase 3 small molecule active

    1 trial

  16. Exoskeletal assisted walking

    United Therapeutics Europe Ltd

    Spinal Cord Injuries

    phase 3 other active

    1 trial

  17. Expanded access program for mepolizumab in subjects with hypereosinophilic syndrome.

    GlaxoSmithKline

    Hypereosinophilic Syndrome

    phase 3 other active

    1 trial

  18. Expanded autologous adipose-derived adult stem cells (eASCs)

    Takeda

    Complex Perianal Fistula

    phase 3 small molecule terminated

    1 trial

  19. Exparel

    Pacira Ireland Limited

    Postoperative Pain Management

    phase 3 small molecule completed

    3 trials

  20. Exparel

    Pacira Ireland Limited

    Back Pain

    phase 3 small molecule active

    1 trial

  21. Exparel

    Pacira Ireland Limited

    Mammaplasty

    phase 3 small molecule completed

    1 trial

  22. Exparel

    Pacira Ireland Limited

    Chronic Shoulder Pain

    phase 3 small molecule active

    1 trial

  23. Exparel

    Pacira Ireland Limited

    Lower Extremity Surgery

    phase 3 small molecule completed

    1 trial

  24. Exparel Injectable Product

    Pacira Ireland Limited

    Coronary Artery Disease

    phase 3 small molecule completed

    1 trial

  25. Experimental vaccine

    Sinovac Research and Development Co.,

    Poliomyelitis

    phase 3 mab completed

    1 trial

  26. Experimental: Tezepelumab

    AstraZeneca

    Asthma

    phase 3 mab completed

    1 trial

  27. Experimental: Venetoclax in combination with Decitabine (+-sorafenib)

    Kunming Hope of Health Hospital

    Elderly AML Patients

    phase 3 other active

    1 trial

  28. Expressive Writing

    United Therapeutics Europe Ltd

    Posttraumatic Stress Disorder

    phase 3 other completed

    1 trial

  29. Extended Release Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorder

    phase 3 small molecule completed

    1 trial

  30. Extended Release Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 3 small molecule completed

    1 trial

  31. Extended treatment

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 3 small molecule completed

    1 trial

  32. Extended-release Guanfacine HCl (Intuniv, SPD503)

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    phase 3 small molecule completed

    1 trial

  33. Extended-release Guanfacine Hydrochloride

    Takeda

    Attention-deficit/Hyperactivity Disorder

    phase 3 small molecule completed

    3 trials

  34. Extensively Hydrolyzed formula

    United Therapeutics Europe Ltd

    Cow Milk Allergy

    phase 3 other completed

    1 trial

  35. Eylea (Aflibercept, BAY86-5321)

    Regeneron UK Limited

    Retinopathy of Prematurity (ROP)

    phase 3 small molecule completed

    2 trials

  36. Eylea 40 mg/mL solution for injection in a vial

    Lacuna Pharma Pty Ltd

    Retinopathy of prematurity (ROP)

    phase 3 small molecule active

    1 trial

  37. FAMPRIDINE, Placebo 515

    Pari Pharma GmbH

    Spinocerebellar ataxia

    phase 3 small molecule active

    1 trial

  38. FAT EMULSIONS , Triheptanoin

    Lacuna Pharma Pty Ltd

    Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)

    phase 3 small molecule active

    1 trial

  39. FE 999326

    Ferring Pharmaceuticals

    Bladder Cancer

    phase 3 small molecule active

    1 trial

  40. FE 999913 vaginal tablet

    Ferring Pharmaceuticals

    Luteal Hormone Supplementation

    phase 3 small molecule completed

    1 trial

  41. FEIBA

    Takeda

    Hemophilia A or B With Inhibitors

    phase 3 mab completed

    1 trial

  42. FET

    Disc Medicine

    ACTH-dependent hypercortisolism

    phase 3 small molecule active

    1 trial

  43. FF

    GlaxoSmithKline

    Rhinitis, Allergic, Perennial

    phase 3 small molecule completed

    1 trial

  44. FF/GW642444 Inhalation Powder

    GlaxoSmithKline

    Pulmonary Disease, Chronic Obstructive

    phase 3 small molecule completed

    2 trials

  45. FF/UMEC/VI

    GlaxoSmithKline

    Asthma

    phase 3 small molecule active

    1 trial

  46. FF/UMEC/VI

    Grace Therapeutics

    Asthma

    phase 3 small molecule active

    1 trial

  47. FIBRINOGEN, HUMAN, RIVAROXABAN , APIXABAN , ETAMSYLATE , TRANEXAMIC ACID , -, PROTAMINE , -, ERYTHROCYTES , AMINOMETHYLBENZOIC ACID , -, AMINOCAPROIC ACID , Ondexxya 200 mg powder for solution for infusion, EDOXABAN , -

    AstraZeneca AB

    Reversal of anticoagulation effect in patients on a FXa inhibitor (apixaban, rivaroxaban, or edoxaban) who require urgent surgery or procedure, and who have a major risk of bleeding.

    phase 3 small molecule active

    1 trial

  48. FILGRASTIM, CYCLOPHOSPHAMIDE, DOXORUBICIN, DEXRAZOXANE HYDROCHLORIDE

    Ningbo Cancer Hospital

    Advanced or metastatic soft tissue sarcoma (STS) in patients ≥65 years old

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.